Show Navigation

Search Results

Refine Search
Match all words
Match any word
Prints
Personal Use
Royalty-Free
Rights-Managed
(leave unchecked to
search all images)
{ 149 images found }

Loading ()...

  • photo by Matt Roth..Delaware residents Martha Layanna and her daughter Mary are part of a class action law suit trying to recoup lost money (approximately $10,000) from Medicare because Martha was, according to them,  improperly classified as an "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Martha and Mary are photographed in Martha's other daughter's home in Newark, Delaware Sunday, August 19, 2012.
    120819 Observed Martha Leyanna 163.JPG
  • photo by Matt Roth..Delaware residents Martha Layanna and her daughter Mary are part of a class action law suit trying to recoup lost money (approximately $10,000) from Medicare because Martha was, according to them,  improperly classified as an "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Martha and Mary are photographed in Martha's other daughter's home in Newark, Delaware Sunday, August 19, 2012.
    120819 Observed Martha Leyanna 125.JPG
  • photo by Matt Roth..Delaware residents Martha Layanna and her daughter Mary are part of a class action law suit trying to recoup lost money (approximately $10,000) from Medicare because Martha was, according to them,  improperly classified as an "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Martha and Mary are photographed in Martha's other daughter's home in Newark, Delaware Sunday, August 19, 2012.
    120819 Observed Martha Leyanna 187.JPG
  • photo by Matt Roth..Delaware residents Martha Layanna and her daughter Mary are part of a class action law suit trying to recoup lost money (approximately $10,000) from Medicare because Martha was, according to them,  improperly classified as an "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Martha and Mary are photographed in Martha's other daughter's home in Newark, Delaware Sunday, August 19, 2012.
    120819 Observed Martha Leyanna 179.JPG
  • photo by Matt Roth..Delaware residents Martha Layanna and her daughter Mary are part of a class action law suit trying to recoup lost money (approximately $10,000) from Medicare because Martha was, according to them,  improperly classified as an "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Martha and Mary are photographed in Martha's other daughter's home in Newark, Delaware Sunday, August 19, 2012.
    120819 Observed Martha Leyanna 176.JPG
  • photo by Matt Roth..Delaware residents Martha Layanna and her daughter Mary are part of a class action law suit trying to recoup lost money (approximately $10,000) from Medicare because Martha was, according to them,  improperly classified as an "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Martha and Mary are photographed in Martha's other daughter's home in Newark, Delaware Sunday, August 19, 2012.
    120819 Observed Martha Leyanna 172.JPG
  • photo by Matt Roth..Delaware residents Martha Layanna and her daughter Mary are part of a class action law suit trying to recoup lost money (approximately $10,000) from Medicare because Martha was, according to them,  improperly classified as an "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Martha and Mary are photographed in Martha's other daughter's home in Newark, Delaware Sunday, August 19, 2012.
    120819 Observed Martha Leyanna 163.JPG
  • photo by Matt Roth..Delaware residents Martha Layanna and her daughter Mary are part of a class action law suit trying to recoup lost money (approximately $10,000) from Medicare because Martha was, according to them,  improperly classified as an "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Martha and Mary are photographed in Martha's other daughter's home in Newark, Delaware Sunday, August 19, 2012.
    120819 Observed Martha Leyanna 141.JPG
  • photo by Matt Roth..Delaware residents Martha Layanna and her daughter Mary are part of a class action law suit trying to recoup lost money (approximately $10,000) from Medicare because Martha was, according to them,  improperly classified as an "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Martha and Mary are photographed in Martha's other daughter's home in Newark, Delaware Sunday, August 19, 2012.
    120819 Observed Martha Leyanna 140.JPG
  • photo by Matt Roth..Delaware residents Martha Layanna and her daughter Mary are part of a class action law suit trying to recoup lost money (approximately $10,000) from Medicare because Martha was, according to them,  improperly classified as an "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Martha and Mary are photographed in Martha's other daughter's home in Newark, Delaware Sunday, August 19, 2012.
    120819 Observed Martha Leyanna 131.JPG
  • photo by Matt Roth..Delaware residents Martha Layanna and her daughter Mary are part of a class action law suit trying to recoup lost money (approximately $10,000) from Medicare because Martha was, according to them,  improperly classified as an "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Martha and Mary are photographed in Martha's other daughter's home in Newark, Delaware Sunday, August 19, 2012.
    120819 Observed Martha Leyanna 125.JPG
  • photo by Matt Roth..Delaware residents Martha Layanna and her daughter Mary are part of a class action law suit trying to recoup lost money (approximately $10,000) from Medicare because Martha was, according to them,  improperly classified as an "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Martha and Mary are photographed in Martha's other daughter's home in Newark, Delaware Sunday, August 19, 2012.
    120819 Observed Martha Leyanna 097.JPG
  • photo by Matt Roth..Delaware residents Martha Layanna and her daughter Mary are part of a class action law suit trying to recoup lost money (approximately $10,000) from Medicare because Martha was, according to them,  improperly classified as an "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Martha and Mary are photographed in Martha's other daughter's home in Newark, Delaware Sunday, August 19, 2012.
    120819 Observed Martha Leyanna 093.JPG
  • photo by Matt Roth..Delaware residents Martha Layanna and her daughter Mary are part of a class action law suit trying to recoup lost money (approximately $10,000) from Medicare because Martha was, according to them,  improperly classified as an "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Martha and Mary are photographed in Martha's other daughter's home in Newark, Delaware Sunday, August 19, 2012.
    120819 Observed Martha Leyanna 090.JPG
  • photo by Matt Roth..Delaware residents Martha Layanna and her daughter Mary are part of a class action law suit trying to recoup lost money (approximately $10,000) from Medicare because Martha was, according to them,  improperly classified as an "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Martha and Mary are photographed in Martha's other daughter's home in Newark, Delaware Sunday, August 19, 2012.
    120819 Observed Martha Leyanna 066.JPG
  • photo by Matt Roth..Delaware residents Martha Layanna and her daughter Mary are part of a class action law suit trying to recoup lost money (approximately $10,000) from Medicare because Martha was, according to them,  improperly classified as an "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Martha and Mary are photographed in Martha's other daughter's home in Newark, Delaware Sunday, August 19, 2012.
    120819 Observed Martha Leyanna 060.JPG
  • photo by Matt Roth..Delaware residents Martha Layanna and her daughter Mary are part of a class action law suit trying to recoup lost money (approximately $10,000) from Medicare because Martha was, according to them,  improperly classified as an "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Martha and Mary are photographed in Martha's other daughter's home in Newark, Delaware Sunday, August 19, 2012.
    120819 Observed Martha Leyanna 054.JPG
  • photo by Matt Roth..Delaware residents Martha Layanna and her daughter Mary are part of a class action law suit trying to recoup lost money (approximately $10,000) from Medicare because Martha was, according to them,  improperly classified as an "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Martha and Mary are photographed in Martha's other daughter's home in Newark, Delaware Sunday, August 19, 2012.
    120819 Observed Martha Leyanna 046.JPG
  • photo by Matt Roth..Delaware residents Martha Layanna and her daughter Mary are part of a class action law suit trying to recoup lost money (approximately $10,000) from Medicare because Martha was, according to them,  improperly classified as an "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Martha and Mary are photographed in Martha's other daughter's home in Newark, Delaware Sunday, August 19, 2012.
    120819 Observed Martha Leyanna 030.JPG
  • photo by Matt Roth..Delaware residents Martha Layanna and her daughter Mary are part of a class action law suit trying to recoup lost money (approximately $10,000) from Medicare because Martha was, according to them,  improperly classified as an "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Martha and Mary are photographed in Martha's other daughter's home in Newark, Delaware Sunday, August 19, 2012.
    120819 Observed Martha Leyanna 022.JPG
  • photo by Matt Roth..Delaware residents Martha Layanna and her daughter Mary are part of a class action law suit trying to recoup lost money (approximately $10,000) from Medicare because Martha was, according to them,  improperly classified as an "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Martha and Mary are photographed in Martha's other daughter's home in Newark, Delaware Sunday, August 19, 2012.
    120819 Observed Martha Leyanna 127.JPG
  • photo by Matt Roth..Every weekend Mike Holt takes his dad out to brunch. This Sunday the two went to Rudy's Family Restaurant in Harrington, DE...Delaware residents Charles Holt and his son Mike are part of a class action law suit trying to recoup lost money (approximately $5,000) from Medicare because Charles was, according to them,  improperly classified as "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Charles and Mike are photographed at the Heritage at Milford assisted living community, where Charles lives Sunday, August 19, 2012.
    120819 Observed Charles Holt 062.JPG
  • photo by Matt Roth..Every weekend Mike Holt takes his dad out to brunch. This Sunday the two went to Rudy's Family Restaurant in Harrington, DE...Delaware residents Charles Holt and his son Mike are part of a class action law suit trying to recoup lost money (approximately $5,000) from Medicare because Charles was, according to them,  improperly classified as "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Charles and Mike are photographed at the Heritage at Milford assisted living community, where Charles lives Sunday, August 19, 2012.
    120819 Observed Charles Holt 049.JPG
  • photo by Matt Roth..Every weekend Mike Holt takes his dad out to brunch. This Sunday the two went to Rudy's Family Restaurant in Harrington, DE...Delaware residents Charles Holt and his son Mike are part of a class action law suit trying to recoup lost money (approximately $5,000) from Medicare because Charles was, according to them,  improperly classified as "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Charles and Mike are photographed at the Heritage at Milford assisted living community, where Charles lives Sunday, August 19, 2012.
    120819 Observed Charles Holt 035.JPG
  • photo by Matt Roth..Every weekend Mike Holt takes his dad out to brunch. This Sunday the two went to Rudy's Family Restaurant in Harrington, DE...Delaware residents Charles Holt and his son Mike are part of a class action law suit trying to recoup lost money (approximately $5,000) from Medicare because Charles was, according to them,  improperly classified as "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Charles and Mike are photographed at the Heritage at Milford assisted living community, where Charles lives Sunday, August 19, 2012.
    120819 Observed Charles Holt 042.JPG
  • photo by Matt Roth..Every weekend Mike Holt takes his dad out to brunch. This Sunday the two went to Rudy's Family Restaurant in Harrington, DE...Delaware residents Charles Holt and his son Mike are part of a class action law suit trying to recoup lost money (approximately $5,000) from Medicare because Charles was, according to them,  improperly classified as "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Charles and Mike are photographed at the Heritage at Milford assisted living community, where Charles lives Sunday, August 19, 2012.
    120819 Observed Charles Holt 042.JPG
  • photo by Matt Roth..Every weekend Mike Holt takes his dad out to brunch. This Sunday the two went to Rudy's Family Restaurant in Harrington, DE...Delaware residents Charles Holt and his son Mike are part of a class action law suit trying to recoup lost money (approximately $5,000) from Medicare because Charles was, according to them,  improperly classified as "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Charles and Mike are photographed at the Heritage at Milford assisted living community, where Charles lives Sunday, August 19, 2012.
    120819 Observed Charles Holt 036.JPG
  • photo by Matt Roth..Delaware residents Charles Holt and his son Mike are part of a class action law suit trying to recoup lost money (approximately $5,000) from Medicare because Charles was, according to them,  improperly classified as "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Charles and Mike are photographed at the Heritage at Milford assisted living community, where Charles lives Sunday, August 19, 2012.
    120819 Observed Charles Holt 172.JPG
  • photo by Matt Roth..Delaware residents Charles Holt and his son Mike are part of a class action law suit trying to recoup lost money (approximately $5,000) from Medicare because Charles was, according to them,  improperly classified as "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Charles and Mike are photographed at the Heritage at Milford assisted living community, where Charles lives Sunday, August 19, 2012.
    120819 Observed Charles Holt 145.JPG
  • photo by Matt Roth..Delaware residents Charles Holt and his son Mike are part of a class action law suit trying to recoup lost money (approximately $5,000) from Medicare because Charles was, according to them,  improperly classified as "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Charles and Mike are photographed at the Heritage at Milford assisted living community, where Charles lives Sunday, August 19, 2012.
    120819 Observed Charles Holt 137.JPG
  • photo by Matt Roth..Delaware residents Charles Holt and his son Mike are part of a class action law suit trying to recoup lost money (approximately $5,000) from Medicare because Charles was, according to them,  improperly classified as "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Charles and Mike are photographed at the Heritage at Milford assisted living community, where Charles lives Sunday, August 19, 2012.
    120819 Observed Charles Holt 127.JPG
  • photo by Matt Roth..Delaware residents Charles Holt and his son Mike are part of a class action law suit trying to recoup lost money (approximately $5,000) from Medicare because Charles was, according to them,  improperly classified as "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Charles and Mike are photographed at the Heritage at Milford assisted living community, where Charles lives Sunday, August 19, 2012.
    120819 Observed Charles Holt 126.JPG
  • photo by Matt Roth..Delaware residents Charles Holt and his son Mike are part of a class action law suit trying to recoup lost money (approximately $5,000) from Medicare because Charles was, according to them,  improperly classified as "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Charles and Mike are photographed at the Heritage at Milford assisted living community, where Charles lives Sunday, August 19, 2012.
    120819 Observed Charles Holt 113.JPG
  • photo by Matt Roth..Delaware residents Charles Holt and his son Mike are part of a class action law suit trying to recoup lost money (approximately $5,000) from Medicare because Charles was, according to them,  improperly classified as "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Charles and Mike are photographed at the Heritage at Milford assisted living community, where Charles lives Sunday, August 19, 2012.
    120819 Observed Charles Holt 068.JPG
  • photo by Matt Roth..Delaware residents Charles Holt and his son Mike are part of a class action law suit trying to recoup lost money (approximately $5,000) from Medicare because Charles was, according to them,  improperly classified as "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Charles and Mike are photographed at the Heritage at Milford assisted living community, where Charles lives Sunday, August 19, 2012.
    120819 Observed Charles Holt 165.JPG
  • photo by Matt Roth..Delaware residents Charles Holt and his son Mike are part of a class action law suit trying to recoup lost money (approximately $5,000) from Medicare because Charles was, according to them,  improperly classified as "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Charles and Mike are photographed at the Heritage at Milford assisted living community, where Charles lives Sunday, August 19, 2012.
    120819 Observed Charles Holt 146.JPG
  • photo by Matt Roth..Delaware residents Charles Holt and his son Mike are part of a class action law suit trying to recoup lost money (approximately $5,000) from Medicare because Charles was, according to them,  improperly classified as "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Charles and Mike are photographed at the Heritage at Milford assisted living community, where Charles lives Sunday, August 19, 2012.
    120819 Observed Charles Holt 136.JPG
  • photo by Matt Roth..Delaware residents Charles Holt and his son Mike are part of a class action law suit trying to recoup lost money (approximately $5,000) from Medicare because Charles was, according to them,  improperly classified as "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Charles and Mike are photographed at the Heritage at Milford assisted living community, where Charles lives Sunday, August 19, 2012.
    120819 Observed Charles Holt 129.JPG
  • photo by Matt Roth..Delaware residents Charles Holt and his son Mike are part of a class action law suit trying to recoup lost money (approximately $5,000) from Medicare because Charles was, according to them,  improperly classified as "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Charles and Mike are photographed at the Heritage at Milford assisted living community, where Charles lives Sunday, August 19, 2012.
    120819 Observed Charles Holt 125.JPG
  • photo by Matt Roth..Delaware residents Charles Holt and his son Mike are part of a class action law suit trying to recoup lost money (approximately $5,000) from Medicare because Charles was, according to them,  improperly classified as "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Charles and Mike are photographed at the Heritage at Milford assisted living community, where Charles lives Sunday, August 19, 2012.
    120819 Observed Charles Holt 123.JPG
  • photo by Matt Roth..Delaware residents Charles Holt and his son Mike are part of a class action law suit trying to recoup lost money (approximately $5,000) from Medicare because Charles was, according to them,  improperly classified as "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Charles and Mike are photographed at the Heritage at Milford assisted living community, where Charles lives Sunday, August 19, 2012.
    120819 Observed Charles Holt 121.JPG
  • photo by Matt Roth..Delaware residents Charles Holt and his son Mike are part of a class action law suit trying to recoup lost money (approximately $5,000) from Medicare because Charles was, according to them,  improperly classified as "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Charles and Mike are photographed at the Heritage at Milford assisted living community, where Charles lives Sunday, August 19, 2012.
    120819 Observed Charles Holt 116.JPG
  • photo by Matt Roth..Delaware residents Charles Holt and his son Mike are part of a class action law suit trying to recoup lost money (approximately $5,000) from Medicare because Charles was, according to them,  improperly classified as "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Charles and Mike are photographed at the Heritage at Milford assisted living community, where Charles lives Sunday, August 19, 2012.
    120819 Observed Charles Holt 114.JPG
  • photo by Matt Roth..Delaware residents Charles Holt and his son Mike are part of a class action law suit trying to recoup lost money (approximately $5,000) from Medicare because Charles was, according to them,  improperly classified as "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Charles and Mike are photographed at the Heritage at Milford assisted living community, where Charles lives Sunday, August 19, 2012.
    120819 Observed Charles Holt 106.JPG
  • photo by Matt Roth..Delaware residents Charles Holt and his son Mike are part of a class action law suit trying to recoup lost money (approximately $5,000) from Medicare because Charles was, according to them,  improperly classified as "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Charles and Mike are photographed at the Heritage at Milford assisted living community, where Charles lives Sunday, August 19, 2012.
    120819 Observed Charles Holt 098.JPG
  • photo by Matt Roth..Delaware residents Charles Holt and his son Mike are part of a class action law suit trying to recoup lost money (approximately $5,000) from Medicare because Charles was, according to them,  improperly classified as "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Charles and Mike are photographed at the Heritage at Milford assisted living community, where Charles lives Sunday, August 19, 2012.
    120819 Observed Charles Holt 091.JPG
  • photo by Matt Roth..Delaware residents Charles Holt and his son Mike are part of a class action law suit trying to recoup lost money (approximately $5,000) from Medicare because Charles was, according to them,  improperly classified as "observation," rather than "in patient." Under the rules of Medicare, more bills are covered under the latter. Charles and Mike are photographed at the Heritage at Milford assisted living community, where Charles lives Sunday, August 19, 2012.
    120819 Observed Charles Holt 073.JPG
  • Rockville, Maryland - February 26, 2016: The vial of Velcade discarded in the Maryland Oncology Hematology medical waste container still has 2.2 mg of the massively expensive drug's original dose of 3.5 mg. The patient's dose called for 1.3 mg. <br />
<br />
<br />
Takeda Pharmaceuticals only sells Velcade, a drug to treat multiple myeloma and lymphoma, in the United States in 3.5 mg vials, which has enough medicine for one day’s treatment for a 6-foot, 6-inch person weighing 290 pounds. If a patient is smaller, much of the powder is put in the trash. <br />
<br />
Pharmaceutical companies in the U.S. sell extra large doses and make big profits on the medical waste.<br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID: 30186899A
    160226_Drug_Waste_166.jpg
  • Rockville, Maryland - February 26, 2016: The vial of Velcade discarded in the Maryland Oncology Hematology medical waste container still has 2.2 mg of the massively expensive drug's original dose of 3.5 mg. The patient's dose called for 1.3 mg. <br />
<br />
<br />
Takeda Pharmaceuticals only sells Velcade, a drug to treat multiple myeloma and lymphoma, in the United States in 3.5 mg vials, which has enough medicine for one day’s treatment for a 6-foot, 6-inch person weighing 290 pounds. If a patient is smaller, much of the powder is put in the trash. <br />
<br />
Pharmaceutical companies in the U.S. sell extra large doses and make big profits on the medical waste.<br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID: 30186899A
    160226_Drug_Waste_161.jpg
  • Rockville, Maryland - February 26, 2016: The Maryland Oncology Hematology patient's dose called for 1.3 mg of Velcade. One vial holds 3.5 mg. The remainder of this very expensive drug will be thrown away in the Rockville, Md, office's trash Friday, February 26, 2016. <br />
<br />
<br />
Takeda Pharmaceuticals only sells Velcade, a drug to treat multiple myeloma and lymphoma, in the United States in 3.5 mg vials, which has enough medicine for one day’s treatment for a 6-foot, 6-inch person weighing 290 pounds. If a patient is smaller, much of the powder is put in the trash. <br />
<br />
Pharmaceutical companies in the U.S. sell extra large doses and make big profits on the medical waste.<br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID: 30186899A
    160226_Drug_Waste_148.jpg
  • Rockville, Maryland - February 26, 2016: Heather Case, RN, prepares an expensive vial of Velcade at Maryland Oncology Hematology office in Rockville, Md., Friday February 26, 2016. One vial of Velcade holds 3.5 mg of powder. An unopened vial holds 3.5 mg of powder. When prepared, Velcade is a liquid drug. The patient receiving this dose only needs 1.3 mg. The remaining amount will be thrown away. <br />
<br />
Takeda Pharmaceuticals only sells Velcade, a drug to treat multiple myeloma and lymphoma, in the United States in 3.5 mg vials, which has enough medicine for one day’s treatment for a 6-foot, 6-inch person weighing 290 pounds. If a patient is smaller, much of the powder is put in the trash. <br />
<br />
Pharmaceutical companies in the U.S. sell extra large doses and make big profits on the medical waste.<br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID: 30186899A
    160226_Drug_Waste_141.jpg
  • Rockville, Maryland - February 26, 2016: An unopened vial of Velcade at a chemotherapy treatment office in Rockville, Md. One vial holds 3.5 mg of powder per vial. The patient receiving this dose only needs 1.3 mg. The remaining amount will be thrown away. <br />
<br />
Takeda Pharmaceuticals only sells Velcade, a drug to treat multiple myeloma and lymphoma, in the United States in 3.5 mg vials, which has enough medicine for one day’s treatment for a 6-foot, 6-inch person weighing 290 pounds. If a patient is smaller, much of the powder is put in the trash. <br />
<br />
Pharmaceutical companies in the U.S. sell extra large doses and make big profits on the medical waste.<br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID: 30186899A
    160226_Drug_Waste_105.jpg
  • Rockville, Maryland - February 26, 2016: Heather Case, RN, prepares an expensive vial of Velcade at Maryland Oncology Hematology office in Rockville, Md., Friday February 26, 2016. One vial of Velcade holds 3.5 mg of powder. An unopened vial holds 3.5 mg of powder. When prepared, Velcade is a liquid drug. The patient receiving this dose only needs 1.3 mg. The remaining amount will be thrown away. <br />
<br />
Takeda Pharmaceuticals only sells Velcade, a drug to treat multiple myeloma and lymphoma, in the United States in 3.5 mg vials, which has enough medicine for one day’s treatment for a 6-foot, 6-inch person weighing 290 pounds. If a patient is smaller, much of the powder is put in the trash. <br />
<br />
Pharmaceutical companies in the U.S. sell extra large doses and make big profits on the medical waste.<br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID: 30186899A
    160226_Drug_Waste_110.jpg
  • Rockville, Maryland - February 26, 2016: Heather Case, RN, prepares an expensive vial of Velcade at Maryland Oncology Hematology office in Rockville, Md., Friday February 26, 2016. One vial of Velcade holds 3.5 mg of powder. An unopened vial holds 3.5 mg of powder. When prepared, Velcade is a liquid drug. The patient receiving this dose only needs 1.3 mg. The remaining amount will be thrown away. <br />
<br />
Takeda Pharmaceuticals only sells Velcade, a drug to treat multiple myeloma and lymphoma, in the United States in 3.5 mg vials, which has enough medicine for one day’s treatment for a 6-foot, 6-inch person weighing 290 pounds. If a patient is smaller, much of the powder is put in the trash. <br />
<br />
Pharmaceutical companies in the U.S. sell extra large doses and make big profits on the medical waste.<br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID: 30186899A
    160226_Drug_Waste_137.jpg
  • Rockville, Maryland - February 26, 2016: An expensive vial of Velcade has been liquified at Maryland Oncology Hematology office in Rockville, Md., Friday February 26, 2016. One vial of Velcade holds 3.5 mg of powder. An unopened vial holds 3.5 mg of powder. When prepared, Velcade is a liquid drug. The patient receiving this dose only needs 1.3 mg. The remaining amount will be thrown away. <br />
<br />
Takeda Pharmaceuticals only sells Velcade, a drug to treat multiple myeloma and lymphoma, in the United States in 3.5 mg vials, which has enough medicine for one day’s treatment for a 6-foot, 6-inch person weighing 290 pounds. If a patient is smaller, much of the powder is put in the trash. <br />
<br />
Pharmaceutical companies in the U.S. sell extra large doses and make big profits on the medical waste.<br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID: 30186899A
    160226_Drug_Waste_132.jpg
  • Rockville, Maryland - February 26, 2016: Heather Case, RN, prepares an expensive vial of Velcade at Maryland Oncology Hematology office in Rockville, Md., Friday February 26, 2016. One vial of Velcade holds 3.5 mg of powder. An unopened vial holds 3.5 mg of powder. When prepared, Velcade is a liquid drug. The patient receiving this dose only needs 1.3 mg. The remaining amount will be thrown away. <br />
<br />
Takeda Pharmaceuticals only sells Velcade, a drug to treat multiple myeloma and lymphoma, in the United States in 3.5 mg vials, which has enough medicine for one day’s treatment for a 6-foot, 6-inch person weighing 290 pounds. If a patient is smaller, much of the powder is put in the trash. <br />
<br />
Pharmaceutical companies in the U.S. sell extra large doses and make big profits on the medical waste.<br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID: 30186899A
    160226_Drug_Waste_123.jpg
  • Rockville, Maryland - February 26, 2016: An unopened vial of Velcade at a chemotherapy treatment office in Rockville, Md. One vial holds 3.5 mg of powder per vial. The patient receiving this dose only needs 1.3 mg. The remaining amount will be thrown away. <br />
<br />
Takeda Pharmaceuticals only sells Velcade, a drug to treat multiple myeloma and lymphoma, in the United States in 3.5 mg vials, which has enough medicine for one day’s treatment for a 6-foot, 6-inch person weighing 290 pounds. If a patient is smaller, much of the powder is put in the trash. <br />
<br />
Pharmaceutical companies in the U.S. sell extra large doses and make big profits on the medical waste.<br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID: 30186899A
    160226_Drug_Waste_102.jpg
  • Rockville, Maryland - February 26, 2016: A post-it-note reminds nurses and pharmacy techs to save partial vials of specific drugs in the Hood room at Maryland Oncology Hematology office in Rockville, Md., Friday February 26, 2016. So called "single dose" vials like Velcade are incredibly expensive, often come in doses too big for an average person, the leftovers of which must be thrown away.<br />
<br />
Takeda Pharmaceuticals only sells Velcade, a drug to treat multiple myeloma and lymphoma, in the United States in 3.5 mg vials, which has enough medicine for one day’s treatment for a 6-foot, 6-inch person weighing 290 pounds. If a patient is smaller, much of the powder is put in the trash. <br />
<br />
Pharmaceutical companies in the U.S. sell extra large doses and make big profits on the medical waste.<br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID: 30186899A
    160226_Drug_Waste_095.jpg
  • Bethesda, Maryland - February 26, 2016: Patricia Taylor mixes a multi dose of Herceptin brand of trastuzumab for a patient in a chemotherapy treatment office in Bethesda, Md., Friday February 26, 2016. None of this drug is wasted. Whatever is left over is stored in the refrigerator. "Every last drop" of this expensive drug is usable, says Taylor. <br />
<br />
However it's not uncommon for her to throw out unused portions of other drugs. <br />
Pharmaceutical companies in the U.S. sell extra large doses and make big profits on the medical waste.<br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID: 30186899A
    160226_Drug_Waste_071.jpg
  • Bethesda, Maryland - February 26, 2016: Patricia Taylor mixes a multi dose of Herceptin brand of trastuzumab for a patient in a chemotherapy treatment office in Bethesda, Md., Friday February 26, 2016. None of this drug is wasted. Whatever is left over is stored in the refrigerator. "Every last drop" of this expensive drug is usable, says Taylor. <br />
<br />
However it's not uncommon for her to throw out unused portions of other drugs. <br />
Pharmaceutical companies in the U.S. sell extra large doses and make big profits on the medical waste.<br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID: 30186899A
    160226_Drug_Waste_066.jpg
  • Bethesda, Maryland - February 26, 2016: An unopened vial of Velcade at a chemotherapy treatment office in Bethesda, Md.<br />
<br />
Takeda Pharmaceuticals only sells Velcade, a drug to treat multiple myeloma and lymphoma, in the United States in 3.5 mg vials, which has enough medicine for one day’s treatment for a 6-foot, 6-inch person weighing 290 pounds. If a patient is smaller, much of the powder is put in the trash. <br />
<br />
Pharmaceutical companies in the U.S. sell extra large doses and make big profits on the medical waste.<br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID: 30186899A
    160226_Drug_Waste_063.jpg
  • Bethesda, Maryland - February 26, 2016: A multi dose of Herceptin brand of trastuzumab waits to be mixed for a patient in a chemotherapy treatment office in Bethesda, Md., Friday February 26, 2016. None of this drug is wasted. Whatever is left over is stored in the refrigerator. "Every last drop" of this expensive drug is usable, says Patricia Taylor, a nurse at the facility. <br />
<br />
However it's not uncommon for her to throw out unused portions of other drugs. <br />
Pharmaceutical companies in the U.S. sell extra large doses and make big profits on the medical waste.<br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID: 30186899A
    160226_Drug_Waste_055.jpg
  • Bethesda, Maryland - February 26, 2016: A multi dose of Herceptin brand of trastuzumab waits to be mixed for a patient in a chemotherapy treatment office in Bethesda, Md., Friday February 26, 2016. None of this drug is wasted. Whatever is left over is stored in the refrigerator. "Every last drop" of this expensive drug is usable, says Patricia Taylor, a nurse at the facility. <br />
<br />
However it's not uncommon for her to throw out unused portions of other drugs. <br />
Pharmaceutical companies in the U.S. sell extra large doses and make big profits on the medical waste.<br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID: 30186899A
    160226_Drug_Waste_053.jpg
  • Bethesda, Maryland - February 26, 2016: Patricia Taylor sits for a portrait where she doses cancer drugs in a chemotherapy treatment office in Bethesda, Md., Friday February 26, 2016. <br />
<br />
A used vial of carfilzomib seen with some of the drug still in the vial will be discarded after use. Once the drug is measured for the appropriate dose for a patient, whatever is left over is thrown away.<br />
<br />
Pharmaceutical companies in the U.S. sell extra large doses and make big profits on the medical waste.<br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID: 30186899A
    160226_Drug_Waste_006.jpg
  • Bethesda, Maryland - February 26, 2016: Patricia Taylor sits for a portrait where she doses cancer drugs in a chemotherapy treatment office in Bethesda, Md., Friday February 26, 2016. <br />
<br />
A used vial of carfilzomib seen with some of the drug still in the vial will be discarded after use. Once the drug is measured for the appropriate dose for a patient, whatever is left over is thrown away.<br />
<br />
Pharmaceutical companies in the U.S. sell extra large doses and make big profits on the medical waste.<br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID: 30186899A
    160226_Drug_Waste_004.jpg
  • Bethesda, Maryland - February 26, 2016: A multi dose of Herceptin brand of trastuzumab waits to be mixed for a patient in a chemotherapy treatment office in Bethesda, Md., Friday February 26, 2016. None of this drug is wasted. Whatever is left over is stored in the refrigerator. "Every last drop" of this expensive drug is usable, says Patricia Taylor, a nurse at the facility. <br />
<br />
However it's not uncommon for her to throw out unused portions of other drugs. <br />
Pharmaceutical companies in the U.S. sell extra large doses and make big profits on the medical waste.<br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID: 30186899A
    160226_Drug_Waste_059.jpg
  • Bethesda, Maryland - February 26, 2016: Patricia Taylor sits for a portrait where she doses cancer drugs in a chemotherapy treatment office in Bethesda, Md., Friday February 26, 2016. Under the hood sits a used vial of carfilzomib, with some of the drug still in the vial. Once she measures the appropriate dose for her patients, she has to throw the rest of the drugs in the vial away. <br />
<br />
Pharmaceutical companies in the U.S. sell extra large doses and make big profits on the medical waste.<br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID: 30186899A
    160226_Drug_Waste_018.jpg
  • Bethesda, Maryland - February 26, 2016: Patricia Taylor sits for a portrait where she doses cancer drugs in a chemotherapy treatment office in Bethesda, Md., Friday February 26, 2016. Once she measures the appropriate dose for her patients, she has to throw the rest of the drugs in the vial away. <br />
<br />
Pharmaceutical companies in the U.S. sell extra large doses and make big profits on the medical waste.<br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID: 30186899A
    160226_Drug_Waste_009.jpg
  • Bethesda, Maryland - February 26, 2016: Patricia Taylor sits for a portrait where she doses cancer drugs in a chemotherapy treatment office in Bethesda, Md., Friday February 26, 2016. Under the hood sits a used vial of carfilzomib, with some of the drug still in the vial. Once she measures the appropriate dose for her patients, she has to throw the rest of the drugs in the vial away. <br />
<br />
Pharmaceutical companies in the U.S. sell extra large doses and make big profits on the medical waste.<br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID: 30186899A
    160226_Drug_Waste_023.jpg
  • Bethesda, Maryland - February 26, 2016: Patricia Taylor sits for a portrait where she doses cancer drugs in a chemotherapy treatment office in Bethesda, Md., Friday February 26, 2016. Under the hood sits a used vial of carfilzomib, with some of the drug still in the vial. Once she measures the appropriate dose for her patients, she has to throw the rest of the drugs in the vial away. <br />
<br />
Pharmaceutical companies in the U.S. sell extra large doses and make big profits on the medical waste.<br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID: 30186899A
    160226_Drug_Waste_020.jpg
  • Allison Pitroff, PA-C, from Canton, left, and Dr. Jesus Esquivel, from Clarkesville, right, suture a patient after receIving HIPEC (Hyperthermic Intraperitoneal Chemotherapy) treatment at St. Agnes Hospital, Wednesday, June 3, 2009. <br />
Dr. Esquivel is the director of the peritoneal surface malignancy program at St. Agnes Healthcare in Baltimore. He hosted eight department of defense doctors instructing them how to conduct heated chemotherapy surgery to a cancer patient from California.
    090603Surgery363.JPG
  • (staff photo by Matt Roth)..David Johnson, who has been diagnosed with the degenerative disease ALS, lays upright on his bed, under a picture depicting Jesus 's resurrection, during the Sykesville man's two-hour morning routine, Wednesday, February 25, 2009. Jesus is on his mind all the time, not just because his illness is terminal, but because he is in the process of writing a theological book arguing against the Calvinist point of Unconditional Election. He credits the book-writing process to prolonging his life, giving him a purpose every day. Ten years with ALS is an unusually long time for a patient to live.
    090225Hospice255.jpg
  • Demencio Lewis, left, walks by Ope Olowomeye, middle, who patiently sits while show coordinator Michelle Saunders labors over her outfit in the Tawes Theater basement dressing room.<br />
Reigning Fashion Battle Champs, Laurel High School, hand over the crown during the 2nd annual contest held at the University of Maryland College Park's Tawes Theatre Saturday January 15, 2005.
    050116FashionShow289bA.jpg
  • Baltimore, Maryland - May 06, 2021: The Center for Psychedelic and Consciousness Research is located inside the Joseph V. Brady Behavioral Biology Research Building, at Johns Hopkins Bayview Medical Center in Baltimore. The center’s work using psilocybin and controlled therapy sessions with patients who suffer from major depression, anorexia, depression associated with Alzheimer’s, nicotine addiction, and depression associated with alcoholism, has shown effectiveness. <br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID:
    210506_Medical_Psychedelics_194.jpg
  • Baltimore, Maryland - May 06, 2021: The Center for Psychedelic and Consciousness Research is located inside the Joseph V. Brady Behavioral Biology Research Building, at Johns Hopkins Bayview Medical Center in Baltimore. The center’s work using psilocybin and controlled therapy sessions with patients who suffer from major depression, anorexia, depression associated with Alzheimer’s, nicotine addiction, and depression associated with alcoholism, has shown effectiveness. <br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID:
    210506_Medical_Psychedelics_190.jpg
  • Baltimore, Maryland - May 06, 2021: One of the therapy rooms at the Center for Psychedelic and Consciousness Research at Johns Hopkins Bayview Medical Center in Baltimore Thursday May 6, 2021. Their work using psilocybin and controlled therapy sessions with patients who suffer from major depression, anorexia, depression associated with Alzheimer’s, nicotine addiction, and depression associated with alcoholism, has shown effectiveness. <br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID:
    210506_Medical_Psychedelics_185.jpg
  • Baltimore, Maryland - May 06, 2021: A leather chair used by the therapists inside a therapy room at the Center for Psychedelic and Consciousness Research at Johns Hopkins Bayview Medical Center in Baltimore Thursday May 6, 2021. Their work using psilocybin and controlled therapy sessions with patients who suffer from major depression, anorexia, depression associated with Alzheimer’s, nicotine addiction, and depression associated with alcoholism, has shown effectiveness. <br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID:
    210506_Medical_Psychedelics_174.jpg
  • Baltimore, Maryland - May 06, 2021: Dr. Roland R. Griffiths, Director of the Center for Psychedelic and Consciousness Research is photographed in the center’s offices at the Johns Hopkins Bayview Medical Center in Baltimore Thursday May 6, 2021. The center uses psilocybin and controlled therapy sessions with patients who suffer from major depression, anorexia, depression associated with Alzheimer’s, nicotine addiction, and depression associated with alcoholism, has shown effectiveness. <br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID:
    210506_Medical_Psychedelics_166.jpg
  • Baltimore, Maryland - May 06, 2021: Dr. Roland R. Griffiths, Director of the Center for Psychedelic and Consciousness Research is photographed in the center’s offices at the Johns Hopkins Bayview Medical Center in Baltimore Thursday May 6, 2021. The center uses psilocybin and controlled therapy sessions with patients who suffer from major depression, anorexia, depression associated with Alzheimer’s, nicotine addiction, and depression associated with alcoholism, has shown effectiveness. <br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID:
    210506_Medical_Psychedelics_150.jpg
  • Baltimore, Maryland - May 06, 2021: Dr. Roland R. Griffiths, Director of the Center for Psychedelic and Consciousness Research is photographed in the center’s offices at the Johns Hopkins Bayview Medical Center in Baltimore Thursday May 6, 2021. The center uses psilocybin and controlled therapy sessions with patients who suffer from major depression, anorexia, depression associated with Alzheimer’s, nicotine addiction, and depression associated with alcoholism, has shown effectiveness. <br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID:
    210506_Medical_Psychedelics_149.jpg
  • Baltimore, Maryland - May 06, 2021: A headphone system, a blood pressure monitor, first aid kit, and a tissue box sit in one of the therapy rooms at the Center for Psychedelic and Consciousness Research at Johns Hopkins Bayview Medical Center in Baltimore Thursday May 6, 2021. Their work using psilocybin and controlled therapy sessions with patients who suffer from major depression, anorexia, depression associated with Alzheimer’s, nicotine addiction, and depression associated with alcoholism, has shown effectiveness. <br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID:
    210506_Medical_Psychedelics_129.jpg
  • Baltimore, Maryland - May 06, 2021: Dr. William Richards is photographed at the Center for Psychedelic and Consciousness Research at Johns Hopkins Bayview Medical Center in Baltimore Thursday May 6, 2021. The center’s work uses psilocybin and controlled therapy sessions with patients who suffer from major depression, anorexia, depression associated with Alzheimer’s, nicotine addiction, and depression associated with alcoholism, has shown effectiveness. <br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID:
    210506_Medical_Psychedelics_118.jpg
  • Baltimore, Maryland - May 06, 2021: Dr. William Richards is photographed at the Center for Psychedelic and Consciousness Research at Johns Hopkins Bayview Medical Center in Baltimore Thursday May 6, 2021. The center’s work uses psilocybin and controlled therapy sessions with patients who suffer from major depression, anorexia, depression associated with Alzheimer’s, nicotine addiction, and depression associated with alcoholism, has shown effectiveness. <br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID:
    210506_Medical_Psychedelics_098.jpg
  • Baltimore, Maryland - May 06, 2021: Headphones, a blood pressure monitor, and a tissue box sit next to the plush couch in one of the therapy rooms at the Center for Psychedelic and Consciousness Research at Johns Hopkins Bayview Medical Center in Baltimore Thursday May 6, 2021. Their work using psilocybin and controlled therapy sessions with patients who suffer from major depression, anorexia, depression associated with Alzheimer’s, nicotine addiction, and depression associated with alcoholism, has shown effectiveness. <br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID:
    210506_Medical_Psychedelics_096.jpg
  • Baltimore, Maryland - May 06, 2021: Paul Stamets, a prominent mushroom expert and protagonist of the film “Fantastic Fungi” drew this picture of a mushroom for Dr. Roland Griffiths which hangs in his office at the Center for Psychedelic and Consciousness Research at Johns Hopkins Bayview Medical Center in Baltimore Thursday May 6, 2021. Their work using psilocybin and controlled therapy sessions with patients who suffer from major depression, anorexia, depression associated with Alzheimer’s, nicotine addiction, and depression associated with alcoholism, has shown effectiveness. <br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID:
    210506_Medical_Psychedelics_082.jpg
  • Baltimore, Maryland - May 06, 2021: A wood carving and a painting of mushrooms that contain psilocybin decorate Dr. Roland Griffiths’s office at the Center for Psychedelic and Consciousness Research at Johns Hopkins Bayview Medical Center in Baltimore Thursday May 6, 2021. Their work using psilocybin and controlled therapy sessions with patients who suffer from major depression, anorexia, depression associated with Alzheimer’s, nicotine addiction, and depression associated with alcoholism, has shown effectiveness. <br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID:
    210506_Medical_Psychedelics_081.jpg
  • Baltimore, Maryland - May 06, 2021: A wood carving of a mushroom that contains psilocybin in Dr. Roland Griffiths’s office at the Center for Psychedelic and Consciousness Research at Johns Hopkins Bayview Medical Center in Baltimore Thursday May 6, 2021. Their work using psilocybin and controlled therapy sessions with patients who suffer from major depression, anorexia, depression associated with Alzheimer’s, nicotine addiction, and depression associated with alcoholism, has shown effectiveness. <br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID:
    210506_Medical_Psychedelics_077.jpg
  • Baltimore, Maryland - May 06, 2021: Dr. William Richards, left, and Dr. Roland R. Griffiths, right, in the front office area of the Center for Psychedelic and Consciousness Research at Johns Hopkins Bayview Medical Center in Baltimore Thursday May 6, 2021. Their work using psilocybin and controlled therapy sessions with patients who suffer from major depression, anorexia, depression associated with Alzheimer’s, nicotine addiction, and depression associated with alcoholism, has shown effectiveness. <br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID:
    210506_Medical_Psychedelics_068.jpg
  • Baltimore, Maryland - May 06, 2021: Dr. William Richards, left, and Dr. Roland R. Griffiths, right, in the front office area of the Center for Psychedelic and Consciousness Research at Johns Hopkins Bayview Medical Center in Baltimore Thursday May 6, 2021. Their work using psilocybin and controlled therapy sessions with patients who suffer from major depression, anorexia, depression associated with Alzheimer’s, nicotine addiction, and depression associated with alcoholism, has shown effectiveness. <br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID:
    210506_Medical_Psychedelics_062.jpg
  • Baltimore, Maryland - May 06, 2021: Dr. William Richards, left, and Dr. Roland R. Griffiths, right, in the front office area of the Center for Psychedelic and Consciousness Research at Johns Hopkins Bayview Medical Center in Baltimore Thursday May 6, 2021. Their work using psilocybin and controlled therapy sessions with patients who suffer from major depression, anorexia, depression associated with Alzheimer’s, nicotine addiction, and depression associated with alcoholism, has shown effectiveness. <br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID:
    210506_Medical_Psychedelics_061.jpg
  • Baltimore, Maryland - May 06, 2021: Dr. William Richards and Dr. Roland R. Griffiths sit on one of their plush couches at the Center for Psychedelic and Consciousness Research at Johns Hopkins Bayview Medical Center in Baltimore Thursday May 6, 2021. Their work using psilocybin and controlled therapy sessions with patients who suffer from major depression, anorexia, depression associated with Alzheimer’s, nicotine addiction, and depression associated with alcoholism, has shown effectiveness. <br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID:
    210506_Medical_Psychedelics_047.jpg
  • Baltimore, Maryland - May 06, 2021: Dr. William Richards and Dr. Roland R. Griffiths sit on one of their plush couches at the Center for Psychedelic and Consciousness Research at Johns Hopkins Bayview Medical Center in Baltimore Thursday May 6, 2021. Their work using psilocybin and controlled therapy sessions with patients who suffer from major depression, anorexia, depression associated with Alzheimer’s, nicotine addiction, and depression associated with alcoholism, has shown effectiveness. <br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID:
    210506_Medical_Psychedelics_045.jpg
  • Baltimore, Maryland - May 06, 2021: Dr. William Richards and Dr. Roland R. Griffiths sit on one of their plush couches at the Center for Psychedelic and Consciousness Research at Johns Hopkins Bayview Medical Center in Baltimore Thursday May 6, 2021. Their work using psilocybin and controlled therapy sessions with patients who suffer from major depression, anorexia, depression associated with Alzheimer’s, nicotine addiction, and depression associated with alcoholism, has shown effectiveness. <br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID:
    210506_Medical_Psychedelics_044.jpg
  • Baltimore, Maryland - May 06, 2021: Dr. Roland R. Griffiths, Director of the Center for Psychedelic and Consciousness Research is photographed at the center’s offices at the Johns Hopkins Bayview Medical Center in Baltimore Thursday May 6, 2021. The center uses psilocybin and controlled therapy sessions with patients who suffer from major depression, anorexia, depression associated with Alzheimer’s, nicotine addiction, and depression associated with alcoholism, has shown effectiveness. <br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID:
    210506_Medical_Psychedelics_035.jpg
  • Baltimore, Maryland - May 06, 2021: Dr. William Richards and Dr. Roland R. Griffiths sit on one of their plush couches at the Center for Psychedelic and Consciousness Research at Johns Hopkins Bayview Medical Center in Baltimore Thursday May 6, 2021. Their work using psilocybin and controlled therapy sessions with patients who suffer from major depression, anorexia, depression associated with Alzheimer’s, nicotine addiction, and depression associated with alcoholism, has shown effectiveness. <br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID:
    210506_Medical_Psychedelics_028.jpg
  • Baltimore, Maryland - May 06, 2021: Dr. William Richards and Dr. Roland R. Griffiths sit on one of their plush couches at the Center for Psychedelic and Consciousness Research at Johns Hopkins Bayview Medical Center in Baltimore Thursday May 6, 2021. Their work using psilocybin and controlled therapy sessions with patients who suffer from major depression, anorexia, depression associated with Alzheimer’s, nicotine addiction, and depression associated with alcoholism, has shown effectiveness. <br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID:
    210506_Medical_Psychedelics_018.jpg
  • Baltimore, Maryland - May 06, 2021: Dr. William Richards and Dr. Roland R. Griffiths sit on one of their plush couches at the Center for Psychedelic and Consciousness Research at Johns Hopkins Bayview Medical Center in Baltimore Thursday May 6, 2021. Their work using psilocybin and controlled therapy sessions with patients who suffer from major depression, anorexia, depression associated with Alzheimer’s, nicotine addiction, and depression associated with alcoholism, has shown effectiveness. <br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID:
    210506_Medical_Psychedelics_021.jpg
  • Baltimore, Maryland - January 27, 2016: Dr. Yoram Unguru, a children's doctor at Sinai in Baltimore is part of a group at the hospital who makes the hard decisions to figure out which patients receive which drugs when supplies are low.<br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID: 30185381A
    160127_Drug_Shortages_211.jpg
  • Baltimore, Maryland - January 27, 2016: Dr. Yoram Unguru, a children's doctor at Sinai in Baltimore is part of a group at the hospital who makes the hard decisions to figure out which patients receive which drugs when supplies are low.<br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID: 30185381A
    160127_Drug_Shortages_199.jpg
  • Baltimore, Maryland - January 27, 2016: Dr. Yoram Unguru, a children's doctor at Sinai in Baltimore is part of a group at the hospital who makes the hard decisions to figure out which patients receive which drugs when supplies are low.<br />
<br />
CREDIT: Matt Roth for The New York Times<br />
Assignment ID: 30185381A
    160127_Drug_Shortages_193.jpg
Next
  • Facebook
  • Twitter
x

Matt Roth Baltimore Photographer Editorial & Commercial

  • Portfolio
  • About
  • Contact
  • Archive
    • All Galleries
    • Search
    • Cart
    • Lightbox
    • Client Area
  • Instagram
  • tumblr